Patents Assigned to REJUVERON TELOMERE THERAPEUTICS AG
  • Patent number: 11964986
    Abstract: The present invention relates to 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b?]dipyridine-8-carboxylic acid derivatives, their manufacture, pharmaceutical compositions containing them and their use as a medicament.
    Type: Grant
    Filed: July 3, 2023
    Date of Patent: April 23, 2024
    Assignee: REJUVERON TELOMERE THERAPEUTICS AG
    Inventors: Patrick Schnider, Fedor Romanov Michailidis, Chien-Chi Hsiao